ProCE Banner Activity

CME

Gastrointestinal Cancers

Slideset Download
Conference Coverage
In this CME-certified downloadable slideset, Thomas H. Cartwright, MD, reviews key studies on the management of GI cancers. Review the slide notes for Dr. Cartwright’s commentary.

Physicians : maximum of 1.00 AMA PRA Category 1 {Credit}

Released: July 31, 2015

Expiration: July 30, 2016

No longer available for credit.

Share

Faculty

Thomas H. Cartwright

Thomas H. Cartwright, MD

US Oncology GI Research

Associate Professor of Medicine

University of Central Florida School of Medicine

Orlando, Florida

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

AstraZeneca

Bayer Healthcare Pharma

Bristol Myers Squibb

Celgene

Genentech BioOncology

Incyte

Novartis Pharmaceuticals Corporation

Target Audience

This program is intended for physicians and other healthcare professionals who provide care for patients with cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply recently presented data to clinical practice to expand treatment options and improve outcomes for patients with GI cancers
  • Identify subpopulations of patients with GI cancers most likely to benefit from a specific treatment plan based on prognostic or predictive markers
  • Discuss new data on novel agents and therapeutic approaches for patients with GI cancers
  • Consider how new trial findings might affect treatment of GI cancers clinical practice in the future

Faculty Disclosure

Primary Author

Thomas H. Cartwright, MD

US Oncology GI Research

Associate Professor of Medicine

University of Central Florida School of Medicine

Orlando, Florida

Thomas H. Cartwright, MD, has disclosed that he has received consulting fees and fees for non-CME services from Amgen, Bayer, BMS, Lilly, and Incyte.

Staff Disclosure

Staff

Davecia Cameron, MS

Managing Editor, Hematology/Oncology

Davecia Cameron, MS,  has no real or apparent conflicts of interest to report.

Kiran Mir-Hudgeons, PhD

Clinical Editor

Kiran Mir-Hudgeons, PhD, has no real or apparent conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from July 31, 2015, through July 30, 2016:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ competence at treating patients with cancer by applying the most recent data from ASCO 2015.